Artosi F, Lanna C, Gaeta Shumak R, Borselli C, Costanza G, Rivieccio A, et al. Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. Dermatol Pract Concept [Internet]. 2025 Oct. 31 [cited 2026 Apr. 21];15(4):5570. Available from: https://dpcj.org/index.php/dpc/article/view/5570